Cytek Biosciences is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/25/18 | undisclosed | Series C |
3E Bioventures Northern Lights Ventures | undisclosed |
| 11/06/20 | $120,000,000 | Series D |
Hillhouse Capital Group LYFE Capital OrbiMed Advisors RA Capital | undisclosed |
